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EchocardiographyAbstract Background: Right ventricular (RV) dysfunction is associated with poor prognosis in
patients with heart failure (HF). Several RV echocardiographic parameters have been proposed
as sensitive markers to detect patients at risk.
Objective: The aim is to compare the predictive value of several RV systolic echocardiographic
parameters for adverse outcome in patients with chronic systolic HF.
Methods: We assessed 117 patients with chronic systolic HF and left ventricular ejection fraction
(LVEF) <40% for the following: (i) RV fractional area change (RVFAC), (ii) tricuspid annular
plane systolic excursion (TAPSE), (iii) integral of the systolic wave (ISWtdi), and (iv) peak systolic
velocity (Satdi). ISWtdi and Satdi were measured using tissue Doppler imaging at the tricuspid annu-
lus. The primary endpoint was death, urgent transplantation, or acute HF episode requiring hospi-
tal admission. The follow-up extended for one year.
Results: Fifty-two patients reached the primary endpoint. The cut-off thresholds for RVFAC,
TAPSE, Satdi, and ISWtdi deﬁned using receiver-operating characteristic curves were 30%,
15.5 mm, 10.0 cm/s, and 2.4 cm, respectively. The area under the curve and the 95% conﬁdence
interval for RVFAC, TAPSE, Satdi, and ISWtdi were 0.71(0.65–0.85), 0.66(0.55–0.76), 0.85(0.70–
0.96), and 0.75(0.64–0.86), respectively. NYHA> 2, and Satdi were found to be independent pre-
dictors of adverse outcome.
Conclusion: Satdi is an independent predictor of adverse outcome in HF at a threshold value of
10.0 cm/s and appears to be superior to other RV systolic echocardiographic parameters.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.1. Introduction
Despite recent advances in diagnosis and treatment, patients
with heart failure (HF) still have a poor prognosis.1,2 It is,
therefore, important to establish a reliable means of identifying
those patients at a higher risk. Right ventricular (RV) systolic
dysfunction (assessed with thermodilution, or radionuclide
318 K.E. Darahimventriculography) in patients with chronic HF is associated
with poor long-term prognosis.3–5 The RV ejection fraction
(EF) predicts death, hospitalization and exercise capacity more
accurately than the maximal oxygen consumption.4
Echocardiography is a non-invasive, inexpensive and read-
ily available method of RV function assessment. However, pre-
cise echocardiographic assessment of RV systolic function is
challenging, primarily because the morphology of RV is com-
plicated. Recently, different echocardiographic parameters
have been proposed for the assessment of RV systolic func-
tion,6 including tricuspid annular plane systolic excursion
(TAPSE) using M-mode,7,8 tissue Doppler imaging (TDI)
measuring the peak systolic velocity (Satdi),
9 and the integral
of the systolic wave (ISWtdi) of the tricuspid annulus.
10 How-
ever, there is still discussion about the best echocardiographic
parameters for predicting outcome in HF.
2. Objective
The aim is to compare the predictive value of several RV echo-
cardiographic parameters for adverse outcome in patients with
chronic systolic heart failure.
3. Methodology
3.1. Patient population
We enrolled 120 consecutive patients with chronic heart failure
evaluated at a tertiary cardiac center from 2009 to 2011. Inclu-Table 1 Baseline demographic and clinical characteristics of the pa
Variables Event
Yes (n= 52)
Age (years) 54.5 ± 14.8
Body surface area (m2) 1.81 ± 0.4
Systolic BP (mmHg) 120 ± 11
Diastolic BP (mmHg) 79 ± 4
Gender
Male 42(80.8%)
Female 10(19.2%)
Etiology of HF
Ischemic 24(46.2%)
Non-ischemic 28(53.8%)
NYHA class III–IV 50(96.2%)
Heart rate 87 ± 5
Hypertension 10(19.2%)
Smoking 14(26.9%)
Diabetes 25(48.1%)
Previous myocardial infarction 19(36.5%)
Previous HF admission 36(69.2%)
Previous PCI 3(5.8%)
Previous CABG 3(5.8%)
B-blockers 36(69.2%)
ACE-inhibitors 48(92.3%)
Diuretics 51(98.1%)
Digitalis 31(59.6%)
Spironolactone 36(69.2%)
Data are expressed as a mean ± standard deviation or a number (percen
heart association; PCI = percutaneous coronary intervention; CABG
enzyme.sion criteria were age >18 years, symptomatic heart failure
(New York Heart Association class II-IV), and left ventricular
ejection fraction (LVEF) <40%. Exclusion criteria were mi-
tral stenosis, mitral valve surgery, severe mitral regurgitation
(>grade 3), severe aortic stenosis (peak velocity >4 m/s), se-
vere tricuspid regurgitation, malignancy, and severe renal fail-
ure requiring dialysis. Detailed medical history and clinical
examination were recorded for all patients. Patients underwent
a detailed echocardiographic assessment within 24 h from
presentation.
The study was approved by the medical ethics committee of
our institution. The study protocol was designed in accordance
with The Code of Ethics of the World Medical Association
(Declaration of Helsinki) for experiments involving humans.
All patients gave informed consent before the procedure.3.2. Echocardiographic examination
Comprehensive transthoracic echocardiography was per-
formed using an Aloka alpha 5 echocardiography machine
(Hitachi Aloka Medical, Ltd., manufactured in Tokyo, Japan)
equipped with tissue Doppler imaging (TDI) technology. Two-
dimensional, M-mode, Doppler echocardiography measure-
ments and quantiﬁcation were performed according to recom-
mendations of the American Society of Echocardiography.11,12
Continuous Doppler echocardiography was used to measure
pulmonary artery and aortic velocities, tricuspid regurgitation
velocity, and mitral regurgitation velocity. Pulsed Doppler
echocardiography for the assessment of the standard diastolictients according to the incidence of primary outcome events.
No (n= 65) p value
54 ± 14 >0.05
1.85 ± 0.2 >0.05
123 ± 12 >0.05
80.3 ± 6 >0.05
45(69.2%) >0.05
20(30.8%)
26(40%) >0.05
39(60%)
39(60%) <0.001
93 ± 20 >0.05
14(21.9%) >0.05
13(20%) >0.05
18(27.7%) <0.05
19(29.2% >0.05
21(32.3%) <0.001
2(3.1%) >0.05
5(7.7%) >0.05
52(80%) >0.05
65(100%) >0.05
57(87.7%) <0.05
27(41.5%) <0.05
32(49.2%) <0.05
t). BP = blood pressure; HF = heart failure; NYHA=New York
= coronary artery bypass surgery; ACE = angiotensin converting
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apical four-chamber view. Thus, the peak early diastolic ﬁlling
velocity (E-wave), early diastolic deceleration time (DT), and
peak late diastolic ﬁlling velocity (A-wave) were recorded.
The systolic pulmonary artery systolic pressure (sPAP) was
assessed by measuring the gradient between the right ventricle
and the right atrium using the peak velocity (Vmax) of the tri-
cuspid regurgitation (sPAP = 4(Vmax)
2 + right atrial pres-
sure). The right atrial pressure was based on both the size of
the inferior vena cava (IVC) and the change in diameter of this
vessel during respiration.13 Pulsed-wave Doppler recording of
the hepatic vein ﬂow was done using a sample volume placed
in the hepatic vein 1 cm proximal to the junction of IVC and
hepatic veins. Hepatic vein systolic/diastolic (S/D) ratio was
calculated. For the right ventricle 2-D and TDI measurements,
care was taken to obtain an ultrasound beam parallel to the
tricuspid annulus motion. The RV endocardium was traced
manually in systole and diastole. The RV fractional area
change (RVFAC) was calculated using the formula: (end-dia-
stolic area  end-systolic area)/end-diastolic area. Tricuspid
annular plane systolic excursion was measured as recom-
mended previously.6 Tricuspid annular TDI was acquired in
the apical 4-chamber view. Peak systolic (Satdi), early diastolic,
and late diastolic velocities of the tricuspid annulus were mea-
sured as recommended previously (sample TDI volume less
than 5 mm and an angle between the TDI sample volume
and the longitudinal myocardial wall vector less than 20).9
The ISWtdi was measured with a minimized gain to obtain
the maximal net border (Pictures 1–4).10 Valvular regurgita-Table 2 Echocardiographic parameters of the patients according to
Variables Event
Yes (n
Left atrial diameter (mm) 48 ±
LV parameters
LV end-diastolic dimension index (mm/m2) 36.7 ±
LV end-systolic dimension index (mm/m2) 32 ±
LV ejection fraction (%) 24.5 ±
Mitral early/late ﬂow velocity 3.5 ±
Mitral E/E0 14.2 +
Mitral deceleration time (ms) 130 ±
Mitral TD systolic velocity (cm/s) 4.5 ±
Mitral TD early diastolic velocity (cm/s) 7.1 ±
Mitral TD late diastolic velocity (cm/s) 3.4 ±
RV parameters
RV end-diastolic area (cm2) 20.3 ±
RV end-systolic area (cm2) 14.5 ±
RV fractional area change (%) 30.1 ±
Tricuspid plane systolic excursion (mm) 15.4 ±
Tricuspid early/late ﬂow velocity 1.2 ±
Tricuspid TD systolic velocity (cm/s) 10.3 ±
Tricuspid TD integral of systolic wave (cm) 2.8 ±
Tricuspid TD early diastolic velocity (cm/s) 10.5 ±
Tricuspid TD late diastolic velocity (cm/s) 9.9 ±
Pulmonary artery systolic pressure (mmHg) 51 ±
Hepatic vein systolic/diastolic ratio 1.1 ±
LV= left ventricle; E/E = early diastolic ﬂow velocity/early diastolic a
mean ± standard deviation or a number (percent).tion was graded according to guidelines of the American Soci-
ety of Echocardiography.14 All parameters were averaged over
three heart cycles (ﬁve cycles for arrhythmia).
3.3. Clinical follow-up and endpoint deﬁnition
Clinical follow-up was for one year. The vital status of each
patient was conﬁrmed by a review of medical records or by
telephone contact (family and/or patient). The primary end-
point was the combined risk of death or urgent heart trans-
plantation or hospitalization for acute HF episode.
Hospitalization for HF was deﬁned as an admission for wors-
ening HF in which intravenous therapy for HF was needed.
The ﬁrst event was considered for each patient.
3.4. Statistical analysis
The data were statistically analyzed using the Statistical Pack-
age for Social Sciences (SPSS) software version 17 (SPSS Inc.,
Chicago, IL, USA). Continuous variables were presented as
mean ± standard deviation and categorical variables as abso-
lute numbers (percentages). Categorical variables were com-
pared by Chi-square test. Continuous normally distributed
variables were compared by two-tailed t-test. The optimal
cut-off for the prediction of primary event was determined
by a receiver-operator characteristic (ROC) curve. The area
under the curve was the primary efﬁcacy measurement. If the
lower 95% CI of the area under the curve was >0.5, we con-
sidered that the parameter may be suitable for a diagnosticthe incidence of primary outcome events.
= 52) No (n= 65) p value
7 43.4 ± 3.9 0.0001
5 35.8 ± 5 >0.05
5 30.2 ± 5 >0.05
5.4 31.4 ± 4.9 0.0001
1.4 2.5 ± 1.7 0.001
5.2 13.4 + 6.5 >0.05
27 143.5 ± 39 0.04
1.4 5.2 ± 1.4 0.007
2.5 7.6 ± 3.3 >0.05
1.2 4.8 ± 2.2 0.001
6 15.9 ± 5 0.001
5 9.9 ± 4 0.001
11 43.7 ± 6 0.025
4.1 17.5 ± 3.9 0.005
0.6 0.90 ± 0.4 0.03
1.7 12.9 ± 1.7 0.0001
1.5 3.4 ± 1.5 0.099
5 10.7 ± 3 0.01
4 12.6 ± 5 0.01
13 39 ± 10.5 0.001
0.5 1.4 ± 0.7 0.086
nnular TD velocity; TD= tissue Doppler. Data are expressed as a
320 K.E. Darahimtest. ROC analysis was used to determine the sensitivity and
speciﬁcity of RV echocardiographic parameters in predicting
the primary endpoint. Logistic regression backward likelihood
ratio technique was used to ﬁnd out the signiﬁcant indepen-
dent predictors of the primary endpoint. A p value 60.05
(2-tailed) was considered signiﬁcant and a p value 60.01 was
considered highly signiﬁcant. Reproducibility of RVFAC,
TAPSE, ISWtdi and Satdi (intra-observer variability) was
assessed by coefﬁcient of variation for repeated measures in
a random sample of 30 patients and was: 4%, 3%, 3%, and
1%, respectively.Figure 1 The receiver-operating characteristic curve for the primar
Satdi = tricuspid TD integral of systolic wave; ISWtdi = tricuspid TD
area change; TAPSE = tricuspid annular plane systolic excursion; AU4. Results
The study included 120 patients with chronic systolic HF and
left ventricular ejection fraction (LVEF) <40%. Follow up
was complete for 117 of 120 patients and the mean (SD) fol-
low-up time was 318 ± 94 days. Fifty-two (44.4%) of 117 pa-
tients reached the primary endpoint (7 deaths, and 45 hospital
admission for HF). The baseline demographic and clinical
characteristics of the studied patients are detailed in Table 1.
Patients with the primary outcome events had a highery endpoint (A) Satdi, (B) ISWtdi, (C) RVFAC, and (D) TAPSE.
integral of systolic wave; RVFAC= right ventricular fractional
C = area under the curve; CI = conﬁdence interval.
Table 3 Diagnostic performance of different RV systolic parameters in prediction of primary events.
Variables Best cut-oﬀ AUC (95% CI) Sensitivity (%) Speciﬁcity (%) PPV (%) NPV (%) p value
Satdi (in cm/s) 10 0.85(0.70–0.96) 92 65 75 93 0.001
ISWtdi (in cm) 2.4 0.75(0.64–0.86) 80 55 58 85 0.001
RVFAC (%) 30 0.71(0.65–0.85) 72 63 67 82 0.001
TAPSE (in mm) 15.5 0.66(0.55–0.76) 75 55 63 80 0.005
AUC= area under the curve; CI = conﬁdence interval; Satdi = tricuspid annular TD peak systolic velocity; ISWtdi = integral of tricuspid
annular systolic wave; RVFAC= right ventricular fractional area change; TAPSE= tricuspid annular plane systolic excursion.
Table 4 Relation of all predictors to the event by logistic
regression analysis.
Variables Beta coeﬃcient Odd’s (95% CI) p value
NYHA class >2 0.98 2.1 (0.9–8.5) <0.001
Satdi 6 10 cm/s 0.30 1.5 (0.2–6.95) <0.05
CI = conﬁdence interval; NYHA=New York Heart Association;
Satdi = Tricuspid annular TD peak systolic velocity.
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class, diabetes, and past heart failure admission. They also
used more diuretics, spironolactone, and digitalis.
Echocardiographic variables in patients with and without
an event are listed in Table 2. For left sided parameters, the
group with outcome events showed signiﬁcantly lower LVEF,
mitral DT, mitral TDI systolic velocity, and mitral TDI late
diastolic velocity, together with higher LA diameter, and mi-
tral E/A ratio. For right-sided parameters, the group with pri-
mary endpoint events showed signiﬁcantly lower RVFAC,
lower TAPSE, and lower Satdi. The ISWtdi showed lower val-
ues with borderline signiﬁcance.Picture 1 Measurement of tricuspid annular systolic wave4.1. Diagnostic performance of different RV systolic parameters
in prediction of primary events
The ROC curves and the area under the curve for each RV sys-
tolic parameter are shown in Fig. 1. The four parameters were
suitable for a diagnostic test as their ROC curve area was signif-
icantly greater than 0.50. The cut-off thresholds for Satdi, ISWtdi,
RVFAC, and TAPSE to predict the primary endpoint were:
10 cm/s, 2.4 cm, 30%, and 15.5 mm, respectively (Table 3).
The Satdi showed the highest diagnostic performance (area
under the curve = 0.85, 95% conﬁdence interval = 0.70–0.96,
sensitivity = 92%, speciﬁcity = 65%, p= 0.0001). The over-
all mean Satdi in the study population was 11.67 ± 2.13 cm/s.
The mean Satdi was lower in patients with an event than in
those without an event (10.3 ± 1.7 vs. 12.9 ± 1.7,
p= 0.0001).
When all the signiﬁcant variables were computed in a mul-
tivariate analysis, only NYHA functional class >II, and Satdi
remained independent predictors of adverse outcomes using
logistic regression analysis (Table 4). Satdi at a threshold of
10 cm/s was the only RV systolic parameter proved to be an
independent predictor of outcome.(Satri) with pulsed-wave tissue Doppler imaging, case 88.
Picture 2 Measurement of tricuspid annular integral of systolic wave (ISWtri) with pulsed-wave tissue Doppler imaging, case 88.
Picture 3 Measurement of tricuspid annular plane systolic excursion, case 88.
322 K.E. Darahim5. Discussion
In the present study, patients with systolic HF were followed
for 1 year to determine the potential prognostic value of sev-
eral RV systolic function parameters. Data analysis revealed
that Satdi is an independent predictor of outcome (death, ur-
gent heart transplantation, or hospitalization for acute HF epi-
sode) in patients with chronic systolic HF with reduced LVEF,
when other important markers such as NYHA and LVEF areconsidered. It also demonstrated that Satdi, with a threshold
value of 10 cm/s, is a better predictor of outcome than other
RV systolic parameters (RVFA, TAPSE, and ISWtdi).
5.1. Right ventricular dysfunction and prognosis in heart failure
RV systolic dysfunction is associated with poor long-term
prognosis in patients with HF.3,4 RVEF (assessed with ther-
modilution, or radionuclide ventriculography) predicts death,
Picture 4 Measurement of right ventricular fractional area change, case 88.
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maximal oxygen consumption.3–5 However, precise echocar-
diographic assessment of RV systolic function is challenging,
primarily because the morphology of RV is complicated.
Two-dimensional echocardiography assessing RV fractional
area change is the mainstay for the analysis of RV function,
but recently, alternative parameters have been suggested,
including TAPSE, Satdi, and ISWtdi.
In the present study, Satdi was shown to be an independent
predictor of outcome. Damy et al.15 studied 136 patients with
stable HF and a left ventricular ejection fraction <35%, and
demonstrated that Satdi predicted of adverse outcome in HF
at a threshold value of 9.5 cm/s. Similarly, Dokainish et al.16
studied patients hospitalized with acute HF, and found that
RV TD systolic velocity predicted cardiac death or rehospital-
ization for HF at a threshold value of 9 cm/s and appeared to
be superior to conventional 2-dimensional parameters of RV
function. Meluzin et al.17 found that a Satdi at a threshold of
10.8 cm/s represented a signiﬁcant independent predictor of
survival and event-free survival in patients with symptomatic
heart failure. This higher threshold in the Meluzin study could
be explained by the lower mean pulmonary artery pressure ob-
served in their patients (28 ± 2 mmHg). Pulmonary artery
pressure determines the RV afterload and is known to be asso-
ciated with a worse RV function.18
5.2. Comparison of the prognostic ability of right ventricular
echocardiographic parameters
The present study demonstrated that Satdi is a better predictor
of outcome than other RV systolic parameters. RVFAC,TAPSE, and ISWtdi were correlated with the combined end-
point; however, they were not independent predictors of prog-
nosis. Similarly, Damy et al.15 demonstrated the superiority of
Satdi at a threshold value of 9.5 cm/s, compared with other
echocardiographic indices of RV systolic function (RVFAC,
TAPSE, and ISWtdi), in predicting event-free survival in pa-
tients with chronic systolic HF. However, they studied patients
one month after stabilization. In our study, we studied patients
within 1 day of presentation whether they were stabilized or
not. This may confer additional prognostic value to ‘‘stable’’
Satdi. The rationale for this would be that a reduced ‘‘strained’’
Satdi value would suggest that the RV is reaching the limit of
its compensatory mechanisms.19
The reason why Satdi was better than the other RV param-
eters is that it overcomes many of the limitations of the tradi-
tional methods of RV assessment. Despite involving the
tricuspid annulus velocity, ISWtdi was not an independent pre-
dictor of mortality. This result could be explained by a weaker
correlation between ISWtdi and the RVEF than Satdi and the
RVEF (r= 0.72, and 0.82, respectively).10 In the present
study, TAPSE had a lower diagnostic performance. This
may result from the higher variability and difﬁculties in
acquiring this measurement, compared with Satdi. Damy
et al. reported a lower sensitivity of TAPSE at a cutoff value
of 13.5 mm, compared to Satdi. A value of 14 mm for TAPSE
was used by Ghio et al. to predict death or urgent transplanta-
tion.20 However, this threshold was not obtained by ROC
curve. This cut-off has subsequently been used in subsequent
studies to determine the prognostic value of RV function.21
The complex shape of the right ventricle may limit the mea-
surement of RVFAC; the endocardial borders are often badly
324 K.E. Darahimdeﬁned due to trabeculations and impede accurate calculation
of the areas of the right ventricular cavity. Similar difﬁculties
have been reported by other observers.22,23
5.3. Limitations of the study
The population studied was relatively small, but despite the
sample size, there was a high event rate (44%). Therefore,
we were able to reach several signiﬁcant conclusions. We ex-
cluded patients with severe tricuspid regurgitation because
the accuracy of the RV systolic parameter has not been estab-
lished in such patients. Furthermore, we did not assess other
RV parameters, such as the myocardial performance index
and myocardial acceleration during isovolumic contraction,
which are also correlated to RV dysfunction and HF progno-
sis.24–27 Finally the present study did not include biological
markers for adverse outcome in heart failure such as brain
natriuretic peptide, but this would have increased the cost of
the present study.
5.4. Conclusion and recommendations
Peak systolic velocity of the tricuspid annulusmeasured in tissue
Doppler imaging is an independent predictor of adverse out-
come in HF at a threshold value of 10.0 cm/s and appears to
be superior to other RV systolic echocardiographic parameters.
In view of the small sample size included in this report, lar-
ger clinical studies are needed to conﬁrm these observations.
Future developments in the ﬁeld of RV dysfunction in the set-
ting of systolic HF may be directed toward assessment of other
indices to accurately describe RV function, ideally being pre-
load- and afterload-independent (such as myocardial accelera-
tion during isovolumic contraction).
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